IN THE NEWS – Myelofibrosis treatment: Effective options & expert care

Patient Power

Jay Yang, M.D., hematologist, medical oncologist and leader of the Hematology Oncology Multidisciplinary Team, explains the types of treatments available to myelofibrosis (MF) patients depending on their risk. Genetic mutations, chronic inflammation, certain blood disorders or having been exposed to certain industrial chemicals can influence a person’s risk of developing MF.

Read the article here.